. Author manuscript; available in PMC: 2016 Apr 12.

Published in final edited form as: Diabetes Metab Res Rev. 2015 Jan;31(1):39–49. doi: 10.1002/dmrr.2542

Table 1.

Blood glucose and body weight measurements

	Body weight (g)	Blood Glucose (mg/dl)
Control	24.19 ± 0.48^*	132.3 ± 0.89^*
Control + DHMEQ	25.88 ± 1.06^*	141.6 ± 3.28^*
Control + IKK-NBD peptide	25.52 ± 0.81^*	140 ± 7.0^*
db⁻/db⁻	42.29 ± 0.57	393.7 ± 20.17
db⁻/db⁻ + DHMEQ	41.33 ± 0.63	401.6 ± 20.12
db⁻/db⁻ + IKK-NBD peptide	38.16 ± 0.42	400 ± 14.8
db⁻/db^-p-50NFkB-/-	38.58 ± 1.90	340.03 ± 18.12
db⁻/db^-PARP-1-/-	38.81 ± 2.11	380.42±11.44

Data (means ± SE)

Blood glucose and body weight measurements from control, type 2 diabetic mice (db⁻/db⁻) treated with and without DHMEQ or IKK-NBD peptide, double knockout mice db⁻/db^-p50NFκB and double knockout db⁻/db^-PARP-1.

P < 0.05 for control, control treated with DHMEQ or IKK-NBD vs. db−/db−, db−/db− treated with DHMEQ or IKK-NBD, db⁻/db^-p50NFκB and double knockout db−/db^-PARP-1.